We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gold Nanoparticles Engineered to Be Capable of Unraveling DNA

By LabMedica International staff writers
Posted on 02 Jul 2012
New findings show that gold nanoparticles with a slight positive charge work together to “unzip” DNA’s double helix. More...
This discovery has implications for gene therapy research and the developing field of DNA-based electronics.

As the nanoparticles cluster together, they pull the strands of DNA apart. “We began this work with the goal of improving methods of packaging genetic material for use in gene therapy,” said Dr. Anatoli Melechko, an associate professor of materials science and engineering at North Carolina State University (NC State; Raleigh, USA) and coauthor of an article describing the research.

The research team introduced gold nanoparticles, approximately 1.5 nm in diameter, into a solution containing double-stranded DNA. The nanoparticles were coated with organic molecules called ligands. Some of the ligands held a positive charge, while others were hydrophobic. Because the gold nanoparticles had a slight positive charge from the ligands, and DNA is always negatively charged, the DNA and nanoparticles were pulled together into complex packages. “However, we found that the DNA was actually being unzipped by the gold nanoparticles,” stated Dr. Melechko. The positively-charged ligands on the nanoparticles attached to the DNA as predicted, but the hydrophobic ligands of the nanoparticles became tangled with each other. As this tangling pulled the nanoparticles into clusters, the nanoparticles pulled the DNA apart.

“We think gold nanoparticles still hold promise for gene therapy,” said Dr. Yaroslava Yingling, an assistant professor of materials science and engineering at NC State and co-author of the paper. “But it’s clear that we need to tailor the ligands, charge and chemistry of these materials to ensure the DNA’s structural integrity is not compromised.”

The finding is also pertinent to research on DNA-based electronics, which has the potential to utilize DNA as a template for creating nanoelectronic circuits. Because some work in that field involves placing metal nanoparticles on DNA, this finding indicates that researchers will have to pay close attention to the characteristics of those nanoparticles--or risk damaging the structural integrity of the DNA.

The study’s findings were published online June 19, 2012, in the journal Advanced Materials.

Related Links:
North Carolina State University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.